Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Organon and Co
Age
6–14
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Pediatric Bronchial Asthma Patients Aged 6 To 14 Years (At The Beginning Of The Treatment Period)
The Severity Must Be Mild, Moderate Or Severe, Persistent Bronchial Asthma
The Patient Must Have Symptoms That Can Be Used As Efficacy Variables (Such As Repeated Coughing And Mild Or Moderate Asthma Attacks) During The Observation Period, And Must Be Using Inhaled Steroids
You may not be if
Patient Using Anti-Asthma Treatment Or Therapy Including corticosteroids Or Oral Anti-Allergic Drugs
Patient With Complications That Will Impair The Judgment Of Efficacy Of This Drug
Patient With Convulsive Disorders Such As Epilepsy Or Such A History
Patient With Liver Disease, Renal Impairment, Heart Disease Or Such Other Complication
